Duly Health and Care

Joliet, Illinois 60435

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Colorectal Cancer, Esophageal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Pancreas Cancer, Relapsed Small Cell Lung Cancer, Skin Cancer, Stomach Cancer, Triple Negative Breast Cancer

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) — Completed
• Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer — Stopped early